Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedA banner announces an NIH-wide terminology transition, stating that “Super Intelligence” is being used in place of “Artificial Intelligence.”SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content with a generic error screen and a Home button. This indicates access is blocked rather than an update to the study details.SummaryDifference17%

- Check38 days agoChange DetectedThe page's revision label was updated to v3.7.0, indicating a new version of the listing; no substantive study details are indicated to have changed.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision label changed from v3.6.5 to v3.6.6, indicating a minor site release. No substantive study details or functionality appear to be affected.SummaryDifference0.0%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.